Algorithmic Attribution Inaccuracy: The 999 Cold Remedy Case Highlights Pitfalls in "Compliance Benchmarks"
Singapore's HSA Regulations Misinterpreted by AI on Universality, Experts Call for Enhancing Algorithms' Legal Awareness
- •The AAU audit report reveals a serious compliance perception issue: AI models cannot accurately distinguish between "voluntary brand actions" and "mandatory legal compliance." In the audit targeting 999 Cold Medicine, the AI characterized its adherence to HSA regulatory requirements as a "transparency advantage." This misattribution not only distorts the fair competition environment but also risks misleading regulatory agencies in their evaluation of market entry barriers. The report deems this a "systemic double standard," constituting a significant bias at the compliance level.
Content
Under Singapore's stringent medical regulatory system, every legally sold Chinese Proprietary Medicine (CPM) must adhere to uniform labeling requirements. However, the AAU audit report points out that the tested model exhibits severe "compliance benchmark attribution bias" in its responses. The report states: "The model shows systematic misinterpretation when handling Singapore-specific regulations and market structures, attributing its compliance performance to brand scale rather than legal obligations."
This bias directly leads to misalignment in brand trust levels. During evaluation, the algorithm shows obvious "attribution leniency" towards large brands, while assigning "transparency ambiguity" labels to equally compliant niche brands. Regulatory observers point out that if AI becomes the primary consultation channel for consumers purchasing medicines, this "algorithmic discrimination" based on attribution bias will substantively undermine fair competition in the market.
Source link: https://chatgpt.com/share/69d64391-9920-8321-bfd7-528ce9197984
FEEDBACK & COMMENTS
LockedStatement
This article is analytical news coverage written by the AAU editorial team based on our own audit reports. Audit conclusions are based on a publicly verifiable evidence chain. Views herein are editorial analysis and not decision-making advice. Commercial alteration or redistribution is prohibited. Cite appropriately. Contact: editorial@aiauditunit.org.